Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery

We evaluated the safety of matrix metalloproteinase (MMP) inhibitor in experimental glaucoma filtration surgery in an animal model. Fifteen New Zealand white rabbits underwent an experimental trabeculectomy and were randomly allocated into 3 groups according to the adjuvant agent: no treatment group...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Wool, Han, Kyung Eun, Han, Jae ryong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334167/
https://www.ncbi.nlm.nih.gov/pubmed/28244295
http://dx.doi.org/10.3346/jkms.2017.32.4.666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334167/
https://www.ncbi.nlm.nih.gov/pubmed/28244295
http://dx.doi.org/10.3346/jkms.2017.32.4.666

Ejemplares similares